Pharmacotherapy

Article	Citations
Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management	83
A guide to therapeutic drug monitoring of β‐lactam antibiotics	70
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19	56
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I	53
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents	43
Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective	39
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review	33
Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide	31
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD	31
Gut microbiome health and dysbiosis: A clinical primer	30
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens	30
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?	29
Optimizing anticoagulation for patients receiving Impella support	27
CBD and THC: Do They Complement Each Other Like Yin and Yang?	26
Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies	26
Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis	25
Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial	25
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn	25
Systematic review and meta‐analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients	22
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline	21
Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID‐19	21
Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review	20
Scoping review of augmented renal clearance in critically ill pediatric patients	19
A systematic review of the drug–drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies	18
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy	18

Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists	18
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists	17
Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta‐Analysis	17
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections	17
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic	17
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta‐analysis	16
Use of direct‐acting oral anticoagulants in solid organ transplantation: A systematic review	16
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients	16
Cisplatin‐induced nephrotoxicity in an outpatient setting	16
Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design	15
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross‐sectional study	15
Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve	15
Use of psychiatric medication by college students: A decade of data	15
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug‐drug interactions according to CYP2D6 phenotypes	15
Prophylactic norepinephrine infusion for postspinal anesthesia hypotension in patients undergoing cesarean section: A randomized, controlled, dose‐finding trial	15
Anticholinergic medication burden and cognitive function in participants of the ASPREE study	15
Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study	14
The impact of statin use prior to intensive care unit admission on critically ill patients with sepsis	14
Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients	14
Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review	14
Multi‐center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity	13
Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling	13
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review	13
Myocardial infarction associated with erenumab: A case report	13
Comprehensive guidance for antibiotic dosing in obese adults: 2022 update	13
A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the	12
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016	12
Pneumococcal vaccination—A literature review and practice guideline update	12
Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections	12
Achievement of goal anti‐Xa activity with weight‐based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients	12
Tebipenem pivoxil hydrobromide—No PICC, no problem!	12
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with	12
Glucagon: Its evolving role in the management of hypoglycemia	12
Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management	12
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease	12
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation	12
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials	12
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and Inter	11
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series	11
The role of inflammation in the pathogenesis and treatment of arrhythmias	11
Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity	11
Methadone‐associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program	11
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease	11
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	11
Reduced alternative insulin dosing in hyperkalemia: A meta‐analysis of effects on hypoglycemia and potassium reduction	10
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non‐ST segment elevation myocardial infarction: A phase Ib/IIa study	10
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial	10
Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline	10
A systematic review of clozapine‐associated inflammation and related monitoring	10
Precision‐based approaches to delirium in critical illness: A narrative review	10

Hydroxychloroquine in Hospitalized Patients with COVID‐19: Real‐World Experience Assessing Mortality	10
Response to intravenous racemic ketamine after switch from intranasal (S)‐ketamine on symptoms of treatment‐resistant depression and post‐traumatic stress disorder in Veterans: A retrospective case se	10
Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis	10
First‐Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area‐Under‐the‐Curve Target Attainment in Critically Ill Patients	9
Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration	9
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics	9
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction	9
Factors influencing antibiotic duration in culture‐negative neonatal early‐onset sepsis	9
Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis	9
Pharmacogenetics ofP2Y12receptor inhibitors	9
Immunosuppression considerations in simultaneous organ transplant	9
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy	9
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2	9
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study	8
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy	8
Restrictive resuscitation in patients with sepsis and mortality: A systematic review and meta‐analysis with trial sequential analysis	8
Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy	8
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures	8
Precision fluid and vasoactive drug therapy for critically ill patients	8
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy	8
Anticoagulation strategies in patients with extracorporeal membrane oxygenation: A network meta‐analysis and systematic review	8
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision	8
The safety of rapid infusion levetiracetam: A systematic review	8
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults	7
Machine learning to predict vasopressin responsiveness in patients with septic shock	7
Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis	7
Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis	7
Patient risk factors for opioid‐related adverse drug events in hospitalized patients: A systematic review	7
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report	7
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies	7
Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta‐analysis	7
Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma	7
Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms	7
Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage	7
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired‐hepatic function	7
Tacrolimus time in therapeutic range and long‐term outcomes in heart transplant recipients	7
Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation	7
Pharmacotherapy for durable left ventricular assist devices	7
Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients	7
Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies	6
Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction	6
TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke	6
Administration of rabies immunoglobulin: Improving evidence‐based guidance for wound infiltration	6
Comparative effectiveness of early‐targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans’ affairs patients with infections due to Clostridioides difficile	6
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application	6
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients	6
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	6
Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration	6
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis	6
New ways of using old antibiotics in pediatrics: Focus on fosfomycin	6
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect	6
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus	5
Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case‐crossover study	5
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis	5
Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists	5
NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life‐threatening severe infections during support with or without extracorporeal membr	5
U.S. trends in prescription nonsteroidal anti‐inflammatory drug use among patients with cardiovascular disease, 1988–2016	5
Comparative effectiveness and safety of high‐dose rivaroxaban and apixaban for atrial fibrillation: A propensity score‐matched cohort study	5
Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies	5
A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors	5
Vancomycin plus ceftaroline for persistent methicillin‐resistant Staphylococcus aureus bacteremia	5
Use of Remdesivir in Myasthenia gravis and COVID‐19	5
Renin‐angiotensin‐aldosterone system inhibitors and major cardiovascular events and acute kidney injury in patients with coronary artery disease	5
Transfer of antibiotics and their metabolites in human milk: Implications for infant health and microbiota	5
Evaluation of Guideline Recommendations for Dual Antipseudomonal Therapy in Hospitalized Adults with Pneumonia Using Combination Antibiograms	5
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan	5
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients	5
Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis	5
Levetiracetam‐associated behavioral adverse events in neurocritical care patients	5
Review of novel β‐lactams and β‐lactam/β‐lactamase inhibitor combinations with implications for pediatric use	5
Risks and mitigation strategies to prevent etoposide infusion‐related reactions in children	5
Insulin NPH for steroid‐induced hyperglycemia: Predictors for success	5
Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review	5
Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection	5
Time to defervescence evaluation for extended‐ vs. standard‐infusion cefepime in patients with acute leukemia and febrile neutropenia	4
Considerations and controversies of pharmacologic management of the pediatric kidney transplant recipient	4
The immunomodulatory effects of opioids and implications for intensive care unit populations	4
Prescribing cascades in ambulatory care: A structured synthesis of evidence	4
Impact of therapeutic plasma exchange on meropenem pharmacokinetics	4
Choice of Acid Suppressant Therapy and Long‐Term Graft Outcomes After Kidney Transplantation	4

Alemtuzumab clearance, lymphocyte count, and T‐cell chimerism after hematopoietic stem cell transplant in sickle cell disease	4
Implications for body weight extremes in solid organ transplantation	4
Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges	4
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction	4
Use of hormonal contraceptives in perimenopause: A systematic review	4
Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort	4
Personalized antiseizure medication therapy in critically ill adult patients	4
From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing	4
Dexmedetomidine for prevention of opioid/benzodiazepine withdrawal syndrome in pediatric intensive care unit: Interim analysis of a randomized controlled trial	4
Optimizing rapid diagnostics and diagnostic stewardship in Gram‐negative bacteremia	4
Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroup	4
Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial	3
Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children	3
A propensity score‐matching analysis of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker exposure on in‐hospital mortality in patients with acute respiratory failure	3
Is ketamine infusion effective and safe as an adjuvant of sedation in the PICU? Results from the Ketamine Infusion Sedation Study (KISS)	3
Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series	3
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study	3
Characterization of antiplatelet response to low‐dose cangrelor utilizing platelet function testing in neuroendovascular patients	3
Elbasvir/grazoprevir administered for 12 weeks via percutaneous endoscopic gastrostomy tube achieves sustained virologic response: A case report and a review of the literature	3
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab	3
The incidence of torsades de pointes with peri‐operative low‐dose ondansetron administration	3
Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase‐negative staphylococcus	3
Renal function estimating equations performance during pregnancy and postpartum	3
Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality	3
Amoxicillin and penicillin G dosing in pediatric community‐acquired pneumococcal pneumonia in the era of conjugate pneumococcal vaccines	3
Analysis of the frequency distribution of five single‐nucleotide polymorphisms of the MTRRgene in a Chinese pediatric population with acute lymphoblastic leukemia	3
	3
Outcomes of adult patients in the intensive care unit with Pseudomonasaeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of res	3
Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients	3
Pre‐transplant amiodarone use does not affect long‐term heart transplant survival	3
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients	3
Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction	3
Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression	3
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	3
Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018	3
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy	3
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps	3
Vancomycin Area Under the Curve‐guided Dosing and Monitoring: “Is the Juice Worth the Squeeze”?	3
Personalizing prevention: Advances in pharmacotherapy for HIV prevention	3
Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies	3
Theophylline for the management of respiratory disorders in adults in the 21st century: A scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network	3
Impact of timing and dosing of four‐factor prothrombin complex concentrate administration on outcomes in warfarin‐associated intracranial hemorrhage	3
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion	3
Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia	3
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy	3
Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study	3
Management of diffuse alveolar hemorrhage in the hematopoietic stem cell transplantation population: A systematic review	3
A systematic review of opioid use and multimodal strategies in solid organ transplant recipients and living donors	3
High prescribing of antibiotics is associated with high prescribing of opioids in medical and dental providers	3
Transitioning disopyramide to mavacamten in obstructive hypertrophic cardiomyopathy: A case series and clinical guide	3
Effects of aging on clinical outcomes in patients receiving genotype‐guided P2Y12 inhibitor selection after percutaneous coronary intervention	3
The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant	3
Removing race and body surface area indexation for estimated kidney function based drug dosing: Aminoglycosides as justification of these principles	3
Association between glucagon‐like peptide‐1 receptor agonists and biliary‐related diseases in patients with type 2 diabetes: A nationwide cohort study	3
The role of tazobactam‐based combinations for the management of infections due to extended‐spectrum β‐lactamase‐producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists	3
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model	3
The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta‐analysis	3
Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors among patients with heart failure with preserved ejection fraction	2
Performance of nasal methicillin‐resistant Staphylococcus aureus screening for intra‐abdominal infections in critically ill adult patients	2
Venlafaxine deprescribing and thyroid function	2
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation	2
Low‐dose adjuvant dexmedetomidine did not decrease propofol sedation requirements in children undergoing gastrointestinal endoscopy	2
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey	2
	2
Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series	2
Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy	2
Open‐source maximum a posteriori‐bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapy	2
Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users	2
Clinical Impact of GLP‐1 receptor agonists in veterans receiving basal‐bolus insulin	2
Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews	2
Approaches to Precision‐based Anticoagulation management in the critically Ill	2
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution	2
Drug repurposing of dextromethorphan as a cellular target for the management of influenza	2
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy	2
Dosing implications for liposomal amphotericin B in pregnancy	2
Treatment of persistent methicillin‐susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate	2
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study	2
Accelerated approval drug labels often lack information for clinical decision‐making	2
Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation	2
Predicting favorable response to intravenous morphine in pediatric critically ill cardiac patients	2
Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score	2
	2
Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients	2
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients	2
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse	2
Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome	2
Current pharmacotherapy management of children and adults with pericarditis: Prospectus for improved outcomes	2
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy	2
Caring for two in the ICU: Pharmacologic management of pregnancy‐related complications	2
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support	2
Comparative effectiveness and safety of prasugrel versus ticagrelor following percutaneous coronary intervention: An observational study	2
A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain	2
Polypharmacy among medicaid‐insured children with and without documented obesity	2
Potential drug–drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross‐sectional study of the National Covid Cohort Collaborative (N3C)	2
Accuracy of a single‐lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy	2